Method and Apparatus for Cancer Screening

A method and apparatus for detection of pteridine levels in a biological sample using CE-LIF which is useful for early cancer screening involving fully oxidizing pteridine compounds in a sample such as a urine sample, subjecting to CE-LIF to assess compound concentration, and compare to expected levels in for healthy or cancer-bearing patients.

Patents:
US 20,110,147,217

Inventor(s): MA YINFA [US]; GIBBONS STEPHEN [US]

Type of Offer: Licensing



Next Patent »
« More Biomedical Patents

Share on      


CrowdSell Your Patent